0
Stop Pills That Kill Act
12/15/2023, 4:07 PM
Summary of Bill S 1475
The Stop Pills That Kill Act includes several key provisions. First, it would require pharmaceutical companies to pay a fee for every opioid prescription they sell, with the funds raised going towards addiction treatment and prevention programs. This fee is intended to hold drug manufacturers accountable for the role their products have played in the opioid epidemic.
Additionally, the bill would establish stricter regulations for the marketing and distribution of prescription opioids. It would require companies to provide more detailed information about the risks and benefits of these drugs to both healthcare providers and patients. The legislation also includes measures to improve monitoring of opioid prescriptions and to crack down on illegal distribution of these medications. Overall, the Stop Pills That Kill Act aims to address the opioid crisis by targeting the root causes of addiction and overdose deaths. By holding pharmaceutical companies accountable for their role in the epidemic and implementing stricter regulations on the marketing and distribution of prescription opioids, this bill seeks to prevent further harm to individuals and communities affected by opioid addiction.
Congressional Summary of S 1475
Stop Pills That Kill Act
This bill increases criminal penalties for offenses relating to the manufacture of fentanyl or counterfeit substances. It also establishes requirements for federal agencies to address the use of counterfeit substances.
Specifically, the bill applies an increased criminal penalty for possessing, manufacturing, or distributing certain equipment or materials that are used to illegally manufacture fentanyl, an analogue of fentanyl, or a counterfeit substance (the increased penalty is currently limited to offenses involving methamphetamine).
The Drug Enforcement Administration must establish and implement a plan to address counterfeit fentanyl or methamphetamine substances through law enforcement action and education and prevention efforts. In addition, the Department of Justice must annually report on the collection of counterfeit fentanyl or methamphetamine substances by law enforcement and on related prosecutions.
